4 not yet recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 4 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus) Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus) | Phase 1 / Phase 2 | Not yet recruiting | George Washington University | 24 | 2027-03-01 | 2026-10-05 |
| Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene No intervention, will not receive any active study intervention, Intravitreal Injection of Ultevursen - Retinitis Pigmentosa (RP), Usher Syndrome Type 2 | Phase 2 | Not yet recruiting | Laboratoires Thea | 81 | 2026-10-05 | 2026-09-01 |
| Clinical Investigation of Safety and Effectiveness for the enVVe® System envve system - Chronic Venous Insufficiency, CVI | Phase 2 / Phase 3 | Not yet recruiting | Hancock Jaffe Laboratiores, Inc | 220 | 2026-07-01 | 2026-05-27 |
| Evaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia Echothiophate Iodide 0.125% Ophthalmic Solution - Refractory Amblyopia | Phase 2 | Not yet recruiting | University of Oklahoma | 20 | 2026-06-01 | 2026-04-28 |
Acidosis, Lactic (1) · Amblyopia (1) · Anxiety Disorders (1) · Blindness, Cortical (1) · Cognition Disorders (1) · Dystonia (1) · Eye Abnormalities (1) · Eye Diseases, Hereditary (1) · Hearing Loss (1) · MELAS Syndrome (1) · Migraine Disorders (1) · Mitochondrial Diseases (1) · Muscular Diseases (1) · Retinal Diseases (1)
Eye Diseases (4) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Sensation Disorders (4) · Signs and Symptoms (4) · Blindness (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Ear Diseases (2) · Genetic Diseases, Inborn (2) · Hearing Disorders (2) · Otorhinolaryngologic Diseases (2)
Echothiophate Iodide (1) · Ophthalmic Solutions (1)
George Washington University (1) · Hancock Jaffe Laboratiores, Inc (1) · Laboratoires Thea (1) · University of Oklahoma (1)
United States (2)
Anne Chiaramello, Ph.D. (1) · Debra Regier, M.D., Ph.D. (1) · Tammy Yanovitch, MD (1) · Wei-Liang Chen, M.D. (1)
UH3TR003897 (1)